These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9061184)

  • 1. Adsorption of immunoglobulin G and anti-factor VIII inhibitory antibody from haemophiliac plasma to derivatized polystyrenes.
    Cornelius RM; Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J; Brash JL
    Biomaterials; 1997 Mar; 18(5):429-36. PubMed ID: 9061184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies.
    Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Biomater Sci Polym Ed; 1994; 6(8):695-705. PubMed ID: 7703186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity of human anti-factor VIII antibodies for functional polystyrene supports.
    Dahri L; Stoltz JF; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Mol Recognit; 1996; 9(5-6):401-6. PubMed ID: 9174917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
    Huguet HC; Lasne D; Rothschild C; Siali R; Jozefonvicz J
    Thromb Haemost; 2004 Feb; 91(2):259-66. PubMed ID: 14961152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patients.
    Boisson-Vidal C; Haouam M; Lakhiari H; Huguet H; Dahri L; Sultan Y; Jozefonvicz J; Siali R
    Vox Sang; 2002 Oct; 83(3):214-21. PubMed ID: 12366762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic sorbents for removal of factor VIII inhibitors from haemophilic A plasma.
    Dahri L; Boisson-Vidal C; Regnault V; Muller D; Sultan Y; Stolz JF
    J Chromatogr B Biomed Appl; 1995 Feb; 664(1):47-54. PubMed ID: 7757240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S; Bayry J; Misra N; Horn MP; Villard S; Pashov A; Stieltjes N; d'Oiron R; Saint-Remy JM; Hoebeke J; Kazatchkine MD; Reinbolt J; Mohanty D; Kaveri SV
    N Engl J Med; 2002 Feb; 346(9):662-7. PubMed ID: 11870243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups.
    Boisson C; Jozefonvicz J; Brash JL
    Biomaterials; 1988 Jan; 9(1):47-52. PubMed ID: 3349121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential new procedure for removing anti-factor VIII antibodies from hemophilic plasma.
    Regnault V; Rivat C; Vallet JP; Francois-Gerard C; Brochier G; Allain JP
    Thromb Res; 1987 Jan; 45(1):51-7. PubMed ID: 3105113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B; Giles A; Samis J; Verbeek K; Mensink E; Novákovà I
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low factor VIII recovery in haemophilia A patients without inhibitor titre is not due to the presence of anti-factor VIII antibodies undetectable by the Bethesda assay.
    Mondorf W; Klinge J; Luban NL; Bray G; Saenko E; Scandella D;
    Haemophilia; 2001 Jan; 7(1):13-9. PubMed ID: 11136375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on a monoclonal antibody to human factor viii coagulant activity, with a description of a facile two-site factor VIII coagulant antigen assay.
    Brown JE; Thuy LP; Carton CL; Hougie C
    J Lab Clin Med; 1983 May; 101(5):793-805. PubMed ID: 6403639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of all anti-factor VIII antibodies in haemophilia A patients by the Bethesda assay and a more sensitive immunoprecipitation assay.
    Klinge J; Auerswald G; Budde U; Klose H; Kreuz W; Lenk H; Scandella D;
    Haemophilia; 2001 Jan; 7(1):26-32. PubMed ID: 11136377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor to factor VIII in mild haemophilia.
    Kesteven PJ; Holland LJ; Lawrie AS; Savidge GF
    Thromb Haemost; 1984 Aug; 52(1):50-2. PubMed ID: 6437010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid acquisition of immunologic tolerance to factor VIII and disappearance of anti-factor VIII IgG4 after prophylactic therapy in a hemophilia A patient with high-titer factor VIII inhibitor.
    Moorehead PC; Thibeault L; Tuttle A; Grabell J; Dwyre L; Silva M; James P; Lillicrap D
    J Pediatr Hematol Oncol; 2015 May; 37(4):e220-2. PubMed ID: 25411864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to human procoagulant factor VIII.
    Rotblat F; Goodall AH; O'Brien DP; Rawlings E; Middleton S; Tuddenham EG
    J Lab Clin Med; 1983 May; 101(5):736-46. PubMed ID: 6403638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies.
    Lubahn BC; Reisner HM
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8232-6. PubMed ID: 2122456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S; Sooryanarayana ; Moreau A; Horn MP; Kazatchkine MD; Kaveri SV
    Chem Immunol; 2000; 77():102-14. PubMed ID: 11706701
    [No Abstract]   [Full Text] [Related]  

  • 19. Precipitating anti-VIII:C antibodies in two patients with haemophilia A.
    Lavergne JM; Meyer D; Girma JP; Larrieu MJ
    Br J Haematol; 1982 Jan; 50(1):135-46. PubMed ID: 6798988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an antibody to factor VIII in a patient with acquired hemophilia with circulating immune complexes.
    Ly B; Michaelsen TE; Dahl O; Frøland SS
    Scand J Haematol; 1982 Feb; 28(2):132-40. PubMed ID: 6806894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.